SenesTech, Inc. Stock price

Equities

SNES

US81720R5054

Biotechnology & Medical Research

Market Closed - Nasdaq 04:30:01 2024-03-28 pm EDT 5-day change 1st Jan Change
0.6825 USD -2.22% Intraday chart for SenesTech, Inc. -9.01% -46.26%
Sales 2024 * 2.25M Sales 2025 * 4.51M Capitalization 3.51M
Net income 2024 * -6M Net income 2025 * -6M EV / Sales 2024 * 1.56 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 0.78 x
P/E ratio 2024 *
-1.03 x
P/E ratio 2025 *
-1.55 x
Employees 25
Yield 2024 *
-
Yield 2025 *
-
Free-Float 99.96%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.22%
1 week-9.01%
Current month-24.12%
1 month-25.00%
3 months-60.55%
6 months-86.79%
Current year-46.26%
More quotes
1 week
0.68
Extreme 0.68
0.73
1 month
0.66
Extreme 0.663
0.91
Current year
0.63
Extreme 0.6291
1.78
1 year
0.52
Extreme 0.52
29.04
3 years
0.52
Extreme 0.52
460.80
5 years
0.52
Extreme 0.52
9 360.00
10 years
0.52
Extreme 0.52
51 288.01
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 22-11-14
Director of Finance/CFO 64 15-08-31
Chief Tech/Sci/R&D Officer - -
Members of the board TitleAgeSince
Director/Board Member 50 15-11-30
Director/Board Member 46 20-11-04
Chairman 51 17-12-31
More insiders
Date Price Change Volume
24-03-28 0.6825 -2.22% 56,250
24-03-27 0.698 +1.29% 42,379
24-03-26 0.6891 -1.77% 34,607
24-03-25 0.7015 +1.96% 40,098
24-03-22 0.688 -8.28% 111,095

Delayed Quote Nasdaq, March 28, 2024 at 04:30 pm EDT

More quotes
SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The Company has two product lines of fertility control products: ContraPest and Evolve. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion. ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program. The Company's technology can also be applied to other mammalian species.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.6825 USD
Average target price
3.5 USD
Spread / Average Target
+412.82%
Consensus
  1. Stock
  2. Equities
  3. Stock SenesTech, Inc. - Nasdaq